Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Comprehensive Analysis of the Waldenström Macroglobulinemia “Cytokine Milieu” Reveals a Novel Role of Rantes Signaling in the Regulation of Immunoglobulin Production

Sherine F. Elsawa, PhD, Anne J. Novak, Ph.D., Steven C Ziesmer, Luciana L Almada, Ph.D., Martin E Fernandez-Zapico, M.D., Thomas E Witzig, M.D., Stephen M. Ansell, M.D./Ph.D.

Blood (2008) 112 (11): 618.

https://doi.org/10.1182/blood.V112.11.618.618

Published: 2008

Journal Articles

miRNA Analysis Identifies a Unique Expression in Waldenström Macroglobulinemia B Cells and Plasma Cells

Sherine F. Elsawa, PhD, Anne J Novak, Ph.D., Deanna Grote, Thomas E Witzig, M.D., Stephen M. Ansell, M.D., Ph.D.

Blood (2008) 112 (11): 620.

https://doi.org/10.1182/blood.V112.11.620.620

Published: 2008

Journal Articles

A Population of Suppressive Monocytes Inhibiting T Cell Proliferation and Dendritic Cell Differentiation in Relapsed Non-Hodgkin’s Lymphoma

Yi Lin, MD, PhD, Peggy A Bulur, B.S., Michael P. Gustafson, Ph.D., Thomas E. Witzig, M.D., Allan B. Dietz, Ph.D.

Blood (2008) 112 (11): 808.

https://doi.org/10.1182/blood.V112.11.808.808

Published: 2008

Journal Articles

Multiplex Analysis of Serum Cytokine Levels in Waldenström Macroglobulinemia Patients.

Sherine F. Elsawa, PhD, Anne J. Novak, Ph.D, Steven C. Ziesmer, Thomas E. Witzig, M.D., Vincent Rajkumar, M.D., Stephen M. Ansell, M.D./Ph.D.

Blood (2007) 110 (11): 2616.

https://doi.org/10.1182/blood.V110.11.2616.2616

Published: 2007

Journal Articles

APRIL-TACI Interactions Mediate Non-Hodgkin Lymphoma B Cell Proliferation through Akt Regulated Cyclin D1 and P21.

Mamta Gupta, PhD, Stephen M. Ansell, M.D./Ph.D., Thomas E. Witzig, M.D., Steven C. Ziesmer, James R. Cerhan, M.D., Stacey R. Dillon, Ph.D., Anne J. Novak, Ph.D.

Blood (2007) 110 (11): 3585.

https://doi.org/10.1182/blood.V110.11.3585.3585

Published: 2007

Journal Articles

Role of CCL5 and Interleukin-6 in the Biology of Waldenström Macroglobulinemia.

Sherine F. Elsawa, PhD, Anne J. Novak, Ph.D., Steven C. Ziesmer, Thomas E. Witzig, M.D., Steven P. Treon, M.D./Ph.D., Steven M. Ansell, M.D./Ph.D.

Blood (2007) 110 (11): 688.

https://doi.org/10.1182/blood.V110.11.688.688

Published: 2007

Journal Articles

Malignant B Cells Skew the Balance between T reg Cell and T H 17 Cell Differentiation in B-Cell Non-Hodgkin Lymphoma (NHL).

Zhi-Zhang Yang, MD, Anne J. Novak, Ph.D., Thomas E. Witzig, M.D., Stephen M. Ansell, M.D., Ph.D.

Blood (2007) 110 (11): 1347.

https://doi.org/10.1182/blood.V110.11.1347.1347

Published: 2007

Journal Articles

Primary Diffuse Large B-Cell Lymphoma of the Colon: Surgery for Local Disease Control Does Not Improve Outcome.

Rajini Katipamula, MBBS, Kay Ristow, Joseph P. Colgan, M.D., Thomas M. Habermann, M.D., Patrick B. Johnston, M.D., Ph.D, David J. Inwards, M.D., Svetomir N. Markovic, M.D., Ph.D, Ivana N. Micallef, M.D., Luis F. Porrata, M.D., William L. White, M.D., Thomas E. Witzig, M.D., Stephen M. Ansell, M.D., Ph.D

Blood (2007) 110 (11): 3444.

https://doi.org/10.1182/blood.V110.11.3444.3444

Published: 2007

Journal Articles

Cardiac Biomarkers Predict for Ability To Tolerate and Complete Therapy with Lenalidomide ± Dexamathosone in AL Amyloidosis.

Angela Dispenzieri, MD, Martha Lacy, M.D., Steven Zeldenrust, M.D., Ph.D., Suzanne R. Hayman, M.D., Shaji Kumar, M.D., Susan M. Geyer, Ph.D., John A. Lust, M.D., Ph.D., Jacob B. Allred, M.S., Thomas E. Witzig, M.D, S. Vincent Rajkumar, M.D., Philip R. Greipp, M.D., Stephen J. Russell, M.D., Ph.D., Brian Kabat, Morie Abraham Gertz, M.D.

Blood (2006) 108 (11): 130.

https://doi.org/10.1182/blood.V108.11.130.130

Published: 2006

Journal Articles

Preferential Inhibition of Malignant Cell Growth by CDDO in Waldenström Macroglobulinemia.

Sherine F. Elsawa, PhD, Anne J. Novak, Ph.D., Marina Konopleva, M.D., Ph.D., Michael Andreeff, M.D., Ph.D., Thomas E. Witzig, M.D., Stephen M. Ansell, M.D., Ph.D.

Blood (2006) 108 (11): 2528.

https://doi.org/10.1182/blood.V108.11.2528.2528

Published: 2006

Journal Articles

Apoptosis Rates in Myeloma Cells Can Be Significantly Affected by CD138 Sorting and by the Specific Method Used To Detect Apoptotic Cells.

Teresa K. Kimlinger, BA, S. Vincent Rajkumar, MD, Michael Kline, Ph.D, Michael M. Timm, Jessica L. Haug, Thomas E. Witzig, M.D, Shaji Kumar, M.D

Blood (2006) 108 (11): 3442.

https://doi.org/10.1182/blood.V108.11.3442.3442

Published: 2006

Journal Articles

Non-Hodgkin Lymphoma B-Cells Induce Intratumoral CD4 + CD25 − T Cells To Express Foxp3 and Gain Regulatory Function.

Zhi-Zhang Yang, MD, Anne J. Novak, Ph.D, Thomas E. Witzig, M.D, Stephen M. Ansell, M.D., Ph.D

Blood (2006) 108 (11): 1724.

https://doi.org/10.1182/blood.V108.11.1724.1724

Published: 2006

Journal Articles

APRIL Promotes Survival and Proliferation of T Cells: Implications for T-Cell Lymphoma.

Zhi-Zhang Yang, M.D., Stephen M. Ansell, M.D., Ph.D., Thomas E. Witzig, M.D., Anne J. Novak, Ph.D.

Blood (2004) 104 (11): 2652.

https://doi.org/10.1182/blood.V104.11.2652.2652

Published: 2004

Journal Articles

PS-341 Induces Selective Radiosensitization of Multiple Myeloma Cells.

Apollina Goel, Ph.D., Angela Dispenzieri, M.D., Philip R. Greipp, M.D., Thomas E. Witzig, M.D., Ruben A. Mesa, M.D., Stephen J. Russell, M.D., Ph.D.

Blood (2004) 104 (11): 2478.

https://doi.org/10.1182/blood.V104.11.2478.2478

Published: 2004

Journal Articles

Fc-Gamma Receptor IIIa and Interferon-Gamma SNPs Do Not Predict Responsiveness of Follicular Lymphoma to Galiximab (Anti-CD80 Antibody).

Myron Czuczman, M.D., Bryan R. Leigh, M.D., Thomas E. Witzig, M.D., Julie M. Vose, M.D., Anas Younes, M.D., Baha Alkuzweny, Ph.D., Anne Larocca, Ph.D., Xianjun Cao, M.S., Aron Thall, Ph.D.

Blood (2004) 104 (11): 3292.

https://doi.org/10.1182/blood.V104.11.3292.3292

Published: 2004

NARROW

Comprehensive Analysis of the Waldenström Macroglobulinemia “Cytokine Milieu” Reveals a Novel Role of Rantes Signaling in the Regulation of Immunoglobulin Production

miRNA Analysis Identifies a Unique Expression in Waldenström Macroglobulinemia B Cells and Plasma Cells

A Population of Suppressive Monocytes Inhibiting T Cell Proliferation and Dendritic Cell Differentiation in Relapsed Non-Hodgkin’s Lymphoma

Multiplex Analysis of Serum Cytokine Levels in Waldenström Macroglobulinemia Patients.

APRIL-TACI Interactions Mediate Non-Hodgkin Lymphoma B Cell Proliferation through Akt Regulated Cyclin D1 and P21.

Role of CCL5 and Interleukin-6 in the Biology of Waldenström Macroglobulinemia.

Malignant B Cells Skew the Balance between T reg Cell and T H 17 Cell Differentiation in B-Cell Non-Hodgkin Lymphoma (NHL).

Primary Diffuse Large B-Cell Lymphoma of the Colon: Surgery for Local Disease Control Does Not Improve Outcome.

Cardiac Biomarkers Predict for Ability To Tolerate and Complete Therapy with Lenalidomide ± Dexamathosone in AL Amyloidosis.

Preferential Inhibition of Malignant Cell Growth by CDDO in Waldenström Macroglobulinemia.

Apoptosis Rates in Myeloma Cells Can Be Significantly Affected by CD138 Sorting and by the Specific Method Used To Detect Apoptotic Cells.

Non-Hodgkin Lymphoma B-Cells Induce Intratumoral CD4 + CD25 − T Cells To Express Foxp3 and Gain Regulatory Function.

APRIL Promotes Survival and Proliferation of T Cells: Implications for T-Cell Lymphoma.

PS-341 Induces Selective Radiosensitization of Multiple Myeloma Cells.

Fc-Gamma Receptor IIIa and Interferon-Gamma SNPs Do Not Predict Responsiveness of Follicular Lymphoma to Galiximab (Anti-CD80 Antibody).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only